Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice

This publication has 42 references indexed in Scilit:

• In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice
  Molecular Therapy, 2004
• Enzyme replacement and enhancement therapies for lysosomal diseases
  Journal of Inherited Metabolic Disease, 2004
• Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs
  Molecular Genetics and Metabolism, 2004
• Gene therapy progress and prospects: gene therapy of lysosomal storage disorders
  Gene Therapy, 2003
• Evaluation of Pathological Manifestations of Disease in Mucopolysaccharidosis VII Mice after Neonatal Hepatic Gene Therapy
  Molecular Therapy, 2002
• Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs
  Proceedings of the National Academy of Sciences, 2002
• Transduction of Hepatocytes after Neonatal Delivery of a Moloney Murine Leukemia Virus Based Retroviral Vector Results in Long-Term Expression of β-Glucuronidase in Mucopolysaccharidosis VII Dogs
  Molecular Therapy, 2002
• Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer
  Gene Therapy, 2001
• Murine Mucopolysaccharidosis VII: Impact of Therapies on the Phenotype, Clinical Course, and Pathology in a Model of a Lysosomal Storage Disease
  Pediatric and Developmental Pathology, 2001
• Prevalence of Lysosomal Storage Disorders
  JAMA, 1999